Bafna Pharmaceuticals Ltd

BAFNAPH

Company Profile

  • Business description

    Bafna Pharmaceuticals Ltd is an Indian pharmaceutical company mainly offering Contract Research and Manufacturing (CRAMS), Technology Transfers, Formulation, and Analytical Development services. It is engaged in the business of manufacturing finished pharmaceutical formulations, specializing in non-betalactam solid oral dosage forms, besides other emerging and potential products and forms in various therapeutic areas such as cardiology, lifestyle and potent drugs, and pain management. The company delivers generic pharmaceutical products for the UK, Australia, the EU, and emerging markets. In addition, it has launched its own brands in Sri Lanka, the Philippines, Tanzania, and Nigeria, offering products for some high-demand therapies like diabetes, cardiovascular, and oncology.

  • Contact

    Thambu Chetty Street
    New No. 68, Old No. 299, Bafna Towers
    ChennaiTN600001
    IND

    T: +91 4425267517

    http://www.bafnapharma.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 March 2026

    Employees

    406

Stocks News & Analysis

stocks

2 ASX shares that benefit from sticky inflation

Inflation is a key risk to shareholders. Here’s why these two ASX shares benefit from higher inflation.
stocks

Our view of Dexus / Scentre deal

Dexus acquires stake in Westfiend Chermside.
stocks

Undervalued ASX retailer benefiting from rebound in spending

Uplift in sales momentum continues.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,923.807.50-0.08%
CAC 408,068.6217.14-0.21%
DAX 4024,186.49108.12-0.45%
Dow JONES (US)48,458.05245.96-0.51%
FTSE 1009,649.0354.13-0.56%
HKSE25,659.15317.64-1.22%
NASDAQ23,195.17398.69-1.69%
Nikkei 22550,168.11668.44-1.31%
NZX 50 Index13,408.141.230.01%
S&P 5006,827.4173.59-1.07%
S&P/ASX 2008,635.008.90-0.10%
SSE Composite Index3,869.3719.97-0.51%

Market Movers